4 completed. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
Follow Intertrigo: new trials by email Literature Review of Intertrigo trials Research Report on Intertrigo
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Efficacy and Safety of Naftin 1% Cream in Adolescent Subjects With Tinea Cruris Naftin 1% Cream, Placebo Cream - Tinea Cruris, Jock Itch | Phase 3 | Completed | Merz North America, Inc. | 65 | 2013-08-01 | 2015-04-15 |
| Safety of a Topical Antifungal Treatment for Tinea Cruris, Tinea Pedis and Tinea Corporis Product 33525 - Tinea Pedis, Tinea Cruris | Phase 3 | Completed | Tinea Pharmaceuticals | 604 | 2011-05-01 | 2013-01-23 |
| Topical Antifungal Treatment for Tinea Cruris 33525, Placebo - Tinea Cruris | Phase 3 | Completed | Medicis Global Service Corporation | 483 | 2011-05-01 | 2013-08-28 |
| Multicenter Study of the Safety and Efficacy of NAFT-500 in Tinea Cruris NAFT-500, Placebo - Tinea Cruris, Jock Itch | Phase 3 | Completed | Merz North America, Inc. | 334 | 2008-09-01 | 2013-04-22 |
Tinea Cruris (4) · Tinea (1) · Tinea Pedis (1)
Bacterial Infections and Mycoses (4) · Dermatitis (4) · Dermatomycoses (4) · Infections (4) · Mycoses (4) · Skin Diseases (4) · Skin Diseases, Eczematous (4) · Skin Diseases, Infectious (4) · Skin and Connective Tissue Diseases (4) · Tinea (3) · Foot Dermatoses (1) · Foot Diseases (1) · Pathological Conditions, Signs and Symptoms (1) · Pruritus (1)
naftifine (1)
Merz North America, Inc. (2) · Medicis Global Service Corporation (1) · Tinea Pharmaceuticals (1)
Belize (3) · Honduras (3) · Puerto Rico (3) · United States (3) · El Salvador (2) · Dominican Republic (1)
Lawrence Parish, MD (1) · Ron Staugaard (1) · Stefan Plaum, MD (1)